|Articles|April 3, 2012

Poll: Do you Recommend IUDs to Nulliparous Women?

A recent study shows that health care professionals continue to have misconceptions about the safety of IUDs for nulliparous women.

A recently published study shows that health care professionals continue to have misconceptions about the safety of IUDs for nulliparous women.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

Kevin Ault, MD, on the maternal and fetal benefits of COVID-19 and flu vaccination in pregnancy

ByKevin Ault, MD

September 4th 2026

FDA working with manufacturers to increase estradiol transdermal patches

FDA working with manufacturers to increase access to estradiol transdermal patches

ByJoshua Fitch, Senior Editor

September 4th 2026

Kevin Ault, MD, on the extended RSV window in ACOG's 2026-27 immunization guidance

ByKevin Ault, MD

September 3rd 2026

David Shalowitz, MD, on strengthened evidence behind salpingectomy for ovarian cancer prevention

ByDavid I. Shalowitz, MD, MSHP

September 3rd 2026

GLP-1 receptor agonists in early pregnancy: What ob-gyns should know

ByElizabeth Jasper, PhD

September 3rd 2026

Latest CME

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Poll: Do you Recommend IUDs to Nulliparous Women?

Related Content

Kevin Ault, MD, on the maternal and fetal benefits of COVID-19 and flu vaccination in pregnancy

FDA working with manufacturers to increase access to estradiol transdermal patches

Kevin Ault, MD, on the extended RSV window in ACOG's 2026-27 immunization guidance

David Shalowitz, MD, on strengthened evidence behind salpingectomy for ovarian cancer prevention

GLP-1 receptor agonists in early pregnancy: What ob-gyns should know

Latest CME

Join Us at The Pathology Meeting in Las Vegas

Join Us at The Pathology Meeting in Las Vegas

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

FDA working with manufacturers to increase access to estradiol transdermal patches

ACOG's 2026-27 respiratory virus immunization recommendations in pregnancy, postpartum

Kevin Ault, MD, on the maternal and fetal benefits of COVID-19 and flu vaccination in pregnancy

Top headlines in women's health from August 2026

GLP-1 receptor agonists in early pregnancy: What ob-gyns should know